19 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

  • Exicure, Inc. XCUR stock increased by 27.4% to $3.12 during Thursday's pre-market session. The market value of their outstanding shares is at $198.3 million. The most recent rating by H.C. Wainwright, on November 06, is at Buy, with a price target of $8.00.
  • ObsEva, Inc. OBSV stock rose 8.6% to $2.91. The market value of their outstanding shares is at $339.3 million. The most recent rating by Credit Suisse, on November 08, is at Neutral, with a price target of $4.00.
  • Acasti Pharma, Inc. ACST shares rose 4.8% to $2.16. The market cap seems to be at $209.4 million. The most recent rating by B. Riley FBR, on August 29, is at Buy, with a price target of $7.75.
  • Qiagen, Inc. QGEN stock rose 3.2% to $36.64. The market cap seems to be at $6.7 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.
  • SINTX Technologies, Inc. SINT shares increased by 3.1% to $2.00. The market cap stands at $4.8 million.
  • Clovis Oncology, Inc. CLVS stock surged 2.9% to $6.74. The market cap seems to be at $173.7 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $3.00.
  • Replimune Group, Inc. REPL shares rose 2.9% to $14.00. The market cap seems to be at $539.2 million. The most recent rating by Roth Capital, on September 04, is at Buy, with a price target of $20.00.
  • Diffusion Pharmaceuticals, Inc. DFFN shares increased by 2.4% to $0.26. The market value of their outstanding shares is at $3.9 million.
  • Reata Pharmaceuticals, Inc. RETA stock surged 1.3% to $190.00. The market value of their outstanding shares is at $6.2 billion. The most recent rating by Citigroup, on November 12, is at Buy, with a price target of $328.00.

 

Losers

  • Lipocine, Inc. LPCN shares decreased by 34.2% to $0.45 during Thursday's pre-market session. The market cap stands at $66.8 million.
  • Jaguar Health, Inc. JAGX shares plummeted 14.4% to $0.89. The market cap seems to be at $8.0 million. The most recent rating by Ladenburg Thalmann, on September 12, is at Buy, with a price target of $5.00.
  • Fulgent Genetics, Inc. FLGT shares declined 12.0% to $12.00. The market cap seems to be at $178.8 million. The most recent rating by Piper Jaffray, on November 05, is at Overweight, with a price target of $12.30.
  • Canopy Growth, Inc. CGC shares decreased by 6.5% to $17.30. The market value of their outstanding shares is at $11.0 billion. The most recent rating by Piper Jaffray, on October 22, is at Overweight, with a price target of $36.00.
  • OrganiGram Holdings, Inc. OGI stock declined 5.2% to $2.38. The market value of their outstanding shares is at $710.5 million.
  • BioCryst Pharmaceuticals, Inc. BCRX shares plummeted 3.1% to $1.55. The market cap seems to be at $220.8 million.
  • Aurora Cannabis, Inc. ACB stock fell 2.3% to $3.46. The market cap stands at $6.3 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Cronos Group, Inc. CRON stock fell 1.6% to $7.14. The market cap seems to be at $3.6 billion. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
  • BioLine Rx, Inc. BLRX stock decreased by 1.5% to $2.63.
  • GlaxoSmithKline, Inc. GSK stock fell 1.2% to $44.12. The most recent rating by Argus Research, on November 11, is at Buy, with a price target of $50.00.

Posted In: Healthcare Stocks Pre-Market MoversTop GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.